Aromatase inhibitor-associated arthralgias: Pathogenesis, frequency and management

Joint Bone Spine

Volumn 74, Issue 6, 2007, Pages 662-663

  Altundag, Kadri ^a   Dede, Didem ^a   Harputluoglu, Hakan ^a   Gullu, Ibrahim ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Aromatase inhibitor; Arthralgia; Breast cancer

Indexed keywords

ANASTROZOLE; ANTIINFLAMMATORY AGENT; AROMATASE INHIBITOR; CODEINE; IBUPROFEN; OPIATE; PARACETAMOL; TAMOXIFEN;

ANTINOCICEPTION; ARTHRALGIA; BONE PAIN; BREAST CANCER; CLINICAL STUDY; DIFFERENTIAL DIAGNOSIS; DRUG ACTIVITY; DRUG WITHDRAWAL; ESTROGEN DEFICIENCY; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FRACTURE; HORMONAL THERAPY; HUMAN; INCIDENCE; LETTER; MUSCULOSKELETAL DISEASE; OSTEOLYSIS; PATHOGENESIS; POSTMENOPAUSE; RISK FACTOR; SIDE EFFECT; TREATMENT INDICATION;

ANTINEOPLASTIC AGENTS, HORMONAL; AROMATASE INHIBITORS; ARTHRALGIA; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MIDDLE AGED; NITRILES; POSTMENOPAUSE; TRIAZOLES;

EID: 36849061619     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2007.04.010     Document Type: Letter

References (8)

1. Altundag K., and Ibrahim N.K. Aromatase inhibitors in breast cancer: an overview. Oncologist 11 (2006) 553-562
2. Felson D.T., and Cummings S.R. Aromatase inhibitors and the syndrome of arthralgias with estrogen deprivation. Arthritis Rheum 52 (2005) 2594-2598
3. Kahn M.F. Does hormone replacement therapy discontinuation cause musculoskeletal pain?. Joint Bone Spine 73 (2006) 488-489
4. Smith I.E., Dowsett M., Ebbs S.R., Dixon J.M., Skene A., Blohmer J.U., et al. Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the immediate preoperative anastrozole, tamoxifen, or combined with tamoxifen (IMPACT) multicenter double-blind randomized trial. J Clin Oncol 23 (2005) 5108-5116
5. Howell A., Cuzick J., Baum M., Buzdar A., Dowsett M., Forbes J.F., et al. Results of the ATAC (arimidex, tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet 365 (2005) 60-62
6. Presant C.A., Kelly C., Bossermann L., Upadhyaya G., Vakil M., Horns R., et al. Aromatase inhibitor-associated arthralgia and bone pain: frequency and characterization in clinical practice. J Clin Oncol 24 (2006) 6137
7. Donnellan P.P., Douglas S.L., Cameron D.A., and Leonard R.C. Aromatase inhibitors and arthralgia. J Clin Oncol 19 (2001) 2767
8. Taylor M, Rastelli A, Civitelli R, Ellis M. Incidence of 25-0H vitamin D deficiency in patients with an history of breast cancer who have musculoskeletal symptomatology. Twenty-seventh San Antonio Breast Cancer Symposium, December 8-11, 2004, Abstract no. 3072.